MBody AI Ltd.
MBAI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.06M
Close$
$-0.02
100.8% downside
Current Fair Value
100.8% downsideOvervalued by 100.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.06 Million |
|---|---|
| Enterprise Value | $2.08 Million |
| Earnings per Share | $4.62 |
| Beta | 0.88 |
| Outstanding Shares | - |
Return
| Return on Equity | -731.71% |
|---|---|
| Return on Assets | -335.95% |
| Return on Invested Capital | -275.30% |
Valuation & Multiples
| P/E Ratio | 0.44 |
|---|---|
| PEG | 0.28 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.22 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 3, 2026
EPS
-$0.02
ReportedRevenue
$1.08 M
ReportedNext Earnings Call
Expected Date
March 3, 2027
EPS Estimate
-$0.01
Consensus analyst estimateRevenue Estimate
$3.68 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Check-Cap Ltd
65 employees
CEO: Guy Neev
Check-Cap is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) preventionthrough the introduction of C-Scan®, thefirst and onlypatient-friendly preparation-freescreening test to detect polypsbeforeth...